Mark Humayun, MD, PhDUniversity Professor, Ophthalmology, Stem Cell Biology and Regenerative Medicine, Biomedical Engineering; Cornelius J. Pings Chair in Biomedical Sciences; Director, USC Ginsburg Institute for Biomedical Therapeutics; Co-Director, USC Roski Eye Institute humayun@usc.edu
Dr. Humayun and his team are inventing new ways to diagnose and treat patients who are either going blind or are blind. The lab’s expertise is to develop abiotic-biotic interfaces with the retina to help restore sight or prevent visual loss. The Humayun lab, collaborating with others, has successfully developed the only FDA-approved artificial retina to restore sight to patients blind from inherited retina degenerations that suffer from photoreceptor loss. The team has also developed a unique scaffold with stem-cell derived retinal pigment epithelium cells for implantation in patients with advanced dry age-related macular degeneration. This stem cell implant is now in FDA clinical trials.
